GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence

CHICAGO, October 16, 2023--Today, GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest addition to the company’s image guided system (IGS) offerings. Allia IGS Pulse features a new imaging chain engineered to provide exceptional imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size.

Related Keywords

France ,Raphael Philippart ,Arnaud Marie ,Yasir Abu Omar ,Clinique Pasteur ,Nicolas Dumonteil ,Twitter ,Ge Healthcare ,Facebook ,Ge Healthcare Technologies Inc ,Patient Care Solutions ,Instagram ,Linkedin ,World Health Organization ,Business Wire ,Focal Spot ,Interventional Cardiologist ,General Manager ,Transcatheter Cardiovascular Therapeutics ,Care Technologies ,Pharmaceutical Diagnostics ,Cardiovascular Diseases ,Accessed February ,Invasive Cardiac ,Thoracic Disease ,Interventional Cardiology ,Image Quality ,Interventional Procedures ,Bags ,Sollia ,Clinicians ,Llia Igs Pulse ,